ALTURiX acquires exclusive UK rights to three new products
The new products are in the areas of gastrointestinal and respiratory medicines
Read More
Tag: gastrointestinal diseases
- Exdensur approved in EU for severe asthma and CRSwNP
- Axol Bioscience acquires Newcells Biotech ophthalmology unit
- Nuclera and leadXpro partner to accelerate structure‑based drug design
- Lundbeck reports positive phase 2b results for migraine prevention drug
- European life sciences coalition launched to boost investment ecosystem
